TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 31 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $17,000 | -67.3% | 109,634 | +397.2% | 0.00% | -100.0% |
| Q2 2015 | $52,000 | -39.5% | 22,052 | +12.9% | 0.00% | -50.0% |
| Q1 2015 | $86,000 | +65.4% | 19,534 | +81.3% | 0.00% | +100.0% |
| Q4 2014 | $52,000 | -50.5% | 10,774 | -2.7% | 0.00% | 0.0% |
| Q4 2013 | $105,000 | – | 11,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clarus Ventures, LLC | 4,644,705 | $19,322,000 | 7.71% |
| First Washington CORP | 185,250 | $771,000 | 0.44% |
| SPHERA FUNDS MANAGEMENT LTD. | 194,200 | $808,000 | 0.10% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 286,801 | $1,173,000 | 0.05% |
| EMERALD ADVISERS, LLC | 175,000 | $728,000 | 0.04% |
| Pine River Capital Management L.P. | 209,900 | $873,000 | 0.01% |
| Alyeska Investment Group, L.P. | 79,196 | $329,000 | 0.01% |
| HighTower Advisors, LLC | 66,514 | $277,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 1,441 | $6,000 | 0.00% |
| First Eagle Investment Management, LLC | 114,456 | $476,000 | 0.00% |